Empire Financial Management Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,234
Closed -$1.59M – 210
2026
Q1
$1.59M Buy
3,234
+248
+8% +$135K 0.36% 80
2025
Q4
$1.73M Buy
2,986
+66
+2% +$37.3K 0.38% 80
2025
Q3
$1.42M Buy
2,920
+188
+7% +$87.5K 0.32% 92
2025
Q2
$1.11M Buy
2,732
+384
+16% +$161K 0.32% 92
2025
Q1
$1.17M Buy
2,348
+218
+10% +$118K 0.36% 84
2024
Q4
$1.11M Buy
2,130
+166
+8% +$91.3K 0.35% 87
2024
Q3
$1.21M Buy
1,964
+38
+2% +$22.5K 0.37% 81
2024
Q2
$1.07M Buy
1,926
+542
+39% +$311K 0.35% 79
2024
Q1
$804K Buy
1,384
+238
+21% +$134K 0.27% 104
2023
Q4
$608K Buy
1,146
+101
+10% +$48.9K 0.24% 107
2023
Q3
$529K Buy
1,045
+32
+3% +$17.1K 0.23% 111
2023
Q2
$529K Buy
1,013
+90
+10% +$48.6K 0.21% 117
2023
Q1
$532K Buy
+923
New +$520K 0.22% 113

Other funds holding TMO

Empire Financial Management Company's TMO Position: Q2 2026 in Review

Empire Financial Management Company sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,234 shares — an estimated $1.59M sold.

Empire Financial Management Company first reported a position in TMO in Q1 2023 and held it in 13 quarters. The position peaked at $1.73M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Empire Financial Management Company reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Empire Financial Management Company sold 3,234 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.59M.
  • Empire Financial Management Company first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 13 quarters.
  • Empire Financial Management Company's Thermo Fisher Scientific position peaked at $1.73M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Empire Financial Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.